MBX Microbix Biosystems

Ontario Helps Microbix Ensure Provincial COVID Testing Capacity

Ontario Helps Microbix Ensure Provincial COVID Testing Capacity
EN
13/10/2020

Underlying

MBXMicrobix Biosystems

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Microbix Biosystems

 PRESS RELEASE
Free
MBX Microbix Biosys...

Microbix Presenting at Muskoka Capital Event

Microbix Presenting at Muskoka Capital Event Meetings with Growth-Oriented Investors, September 26 to 28, 2025 MISSISSAUGA, Ontario, Sept. 25, 2025 (GLOBE NEWSWIRE) -- Microbix Biosystems Inc. (TSX: MBX, OTCQX: MBXBF, Microbix®), a life sciences innovator, manufacturer, and exporter, announces that it will be presenting to investors at the Muskoka Capital Event, organized by Capital Event Management Ltd. and being hosted at the JW Marriott Rosseau Muskoka, in Minett, Ontario, September 26 to 28, 2025. Microbix’s CEO, Cameron Groome, and COO, Ken Hughes, will undertake a series of 18 ...

17h / 32m 1 EN
 PRESS RELEASE
Free
MBX Microbix Biosys...

Microbix Assisting EMQN with Second Genetic-Test EQA Program

Microbix Assisting EMQN with Second Genetic-Test EQA Program Helping Ensure Appropriate Dosing of Widely-Used Anti-Clotting Drugs MISSISSAUGA, Ontario and MANCHESTER, United Kingdom, Sept. 23, 2025 (GLOBE NEWSWIRE) -- Microbix Biosystems Inc. (TSX: MBX, OTCQX: MBXBF, Microbix®), a life sciences innovator, manufacturer, and exporter, and EMQN CIC (EMQN), a global supplier of laboratory external quality assessment (“EQA”) schemes for human genomic testing, announce the go-live of a program to support rapid and accurate identification of patients who carry gene-variants associated with fas...

September 23, 2025 1 EN
 PRESS RELEASE
Free
MBX Microbix Biosys...

Microbix Client Labquality Introduces Novel EQA Scheme at ESCV

Microbix Client Labquality Introduces Novel EQA Scheme at ESCV Supporting Clinical Labs in Accurately Identifying HPV-associated Head and Neck Cancers MISSISSAUGA, Ontario and HELSINKI, Sept. 17, 2025 (GLOBE NEWSWIRE) -- Microbix Biosystems Inc. (TSX: MBX, OTCQX: MBXBF, Microbix®), a life sciences innovator, manufacturer, and exporter, and Labquality Oy (Labquality), announce a novel external quality assessment (“EQA”) program to help ensure clinical laboratories accurately identify head and neck cancers associated with cancer-causing strains of Human Papilloma Virus (“HPV”). Labquality...

September 17, 2025 1 EN
 PRESS RELEASE
Free
MBX Microbix Biosys...

Microbix Hosts Ontario Minister Stephen Crawford

Microbix Hosts Ontario Minister Stephen Crawford Site Visit & Discussions at Biotech Manufacturing Facilities in Mississauga MISSISSAUGA, Ontario, Sept. 03, 2025 (GLOBE NEWSWIRE) -- Microbix Biosystems Inc. (TSX: MBX, OTCQX: MBXBF, Microbix®), a life sciences innovator, manufacturer, and exporter, announces its hosting of the Honourable Stephen Crawford, Ontario’s Minister of Public and Business Service Delivery and Procurement, for a site visit to tour the company’s advanced biotechnology development and manufacturing facilities and discuss how next generation diagnostics can improve h...

September 3, 2025 1 EN
 PRESS RELEASE
Free
MBX Microbix Biosys...

Microbix Reports Results for Q3 Fiscal 2025

Microbix Reports Results for Q3 Fiscal 2025 Revenues of $3.5 million, Weaker Gross Margin, and Net Loss MISSISSAUGA, Ontario, Aug. 14, 2025 (GLOBE NEWSWIRE) -- Microbix Biosystems Inc. (TSX: MBX, OTCQX: MBXBF, Microbix®), a life sciences innovator, manufacturer, and exporter, reports results for its third quarter and nine months of fiscal 2025 ended June 30, 2025 (“Q3” and “YTD”). Sales for Q3 were down for both Antigens and QAPs™, while YTD Antigens were up and QAPs were down YTD. Management DiscussionResults for Q3 were disappointing, impacted by two key events, cancellation of test-...

August 14, 2025 1 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch